The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Urinary Tract Infection (UTI) Market Research Report 2024
Synopsis
Urinary tract infection (UTI), is an infectious disease caused by the growth and proliferation of pathogens in the urinary tract.Pathogens may include bacteria, mycoplasma, chlamydia, viruses, etc.Urinary tract infection is the second most common infectious disease after respiratory tract infection.Shock deaths from urinary tract infections were the third leading cause of death.
The global Urinary Tract Infection (UTI) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Urinary Tract Infection (UTI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urinary Tract Infection (UTI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Urinary Tract Infection (UTI) in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Urinary Tract Infection (UTI) include Novartis AG, GlaxoSmithKline, Dr. Reddy’s Laboratories Ltd.,, Pfizer, Roche, AstraZeneca,, Cipla, Johnson & Johnson and Bayer AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Urinary Tract Infection (UTI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Tract Infection (UTI).
Report Scope
The Urinary Tract Infection (UTI) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urinary Tract Infection (UTI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urinary Tract Infection (UTI) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
GlaxoSmithKline
Dr. Reddy’s Laboratories Ltd.,
Pfizer
Roche
AstraZeneca,
Cipla
Johnson & Johnson
Bayer AG
Teva Pharmaceutical Industries
Boehringer Ingelheim
Sanofi
Lily
Abbott
JinShuiBao
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
Borui Medicine
Zhejiang Xianju Pharmaceutical
Sichuan Guorui Pharmaceutical
Hengrui Pharmaceutical
Segment by Type
By Site of Infection
Upper Urinary Tract Infection
Lower Urinary Tract Infection
By Clinical Symptoms
Symptomatic Urinary Tract Infection
Asymptomatic Urinary Tract Infection
By Presence of Urinary Tract Abnormalities
Simple/uncomplicated Urinary Tract Infection
Complex Urinary Tract Infection
Segment by Application
Hospitals
Clinic
Self-administered
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urinary Tract Infection (UTI) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Urinary tract infection (UTI), is an infectious disease caused by the growth and proliferation of pathogens in the urinary tract.Pathogens may include bacteria, mycoplasma, chlamydia, viruses, etc.Urinary tract infection is the second most common infectious disease after respiratory tract infection.Shock deaths from urinary tract infections were the third leading cause of death.
The global Urinary Tract Infection (UTI) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Urinary Tract Infection (UTI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urinary Tract Infection (UTI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Urinary Tract Infection (UTI) in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Urinary Tract Infection (UTI) include Novartis AG, GlaxoSmithKline, Dr. Reddy’s Laboratories Ltd.,, Pfizer, Roche, AstraZeneca,, Cipla, Johnson & Johnson and Bayer AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Urinary Tract Infection (UTI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Tract Infection (UTI).
Report Scope
The Urinary Tract Infection (UTI) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urinary Tract Infection (UTI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urinary Tract Infection (UTI) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
GlaxoSmithKline
Dr. Reddy’s Laboratories Ltd.,
Pfizer
Roche
AstraZeneca,
Cipla
Johnson & Johnson
Bayer AG
Teva Pharmaceutical Industries
Boehringer Ingelheim
Sanofi
Lily
Abbott
JinShuiBao
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
Borui Medicine
Zhejiang Xianju Pharmaceutical
Sichuan Guorui Pharmaceutical
Hengrui Pharmaceutical
Segment by Type
By Site of Infection
Upper Urinary Tract Infection
Lower Urinary Tract Infection
By Clinical Symptoms
Symptomatic Urinary Tract Infection
Asymptomatic Urinary Tract Infection
By Presence of Urinary Tract Abnormalities
Simple/uncomplicated Urinary Tract Infection
Complex Urinary Tract Infection
Segment by Application
Hospitals
Clinic
Self-administered
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urinary Tract Infection (UTI) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Site of Infection
1.2.1 Global Urinary Tract Infection (UTI) Market Size Growth Rate By Site of Infection: 2019 VS 2023 VS 2030
1.2.2 Upper Urinary Tract Infection
1.2.3 Lower Urinary Tract Infection
1.3 Market by Application
1.3.1 Global Urinary Tract Infection (UTI) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Self-administered
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urinary Tract Infection (UTI) Market Perspective (2019-2030)
2.2 Urinary Tract Infection (UTI) Growth Trends by Region
2.2.1 Global Urinary Tract Infection (UTI) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Urinary Tract Infection (UTI) Historic Market Size by Region (2019-2024)
2.2.3 Urinary Tract Infection (UTI) Forecasted Market Size by Region (2025-2030)
2.3 Urinary Tract Infection (UTI) Market Dynamics
2.3.1 Urinary Tract Infection (UTI) Industry Trends
2.3.2 Urinary Tract Infection (UTI) Market Drivers
2.3.3 Urinary Tract Infection (UTI) Market Challenges
2.3.4 Urinary Tract Infection (UTI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urinary Tract Infection (UTI) Players by Revenue
3.1.1 Global Top Urinary Tract Infection (UTI) Players by Revenue (2019-2024)
3.1.2 Global Urinary Tract Infection (UTI) Revenue Market Share by Players (2019-2024)
3.2 Global Urinary Tract Infection (UTI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Urinary Tract Infection (UTI) Revenue
3.4 Global Urinary Tract Infection (UTI) Market Concentration Ratio
3.4.1 Global Urinary Tract Infection (UTI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urinary Tract Infection (UTI) Revenue in 2023
3.5 Urinary Tract Infection (UTI) Key Players Head office and Area Served
3.6 Key Players Urinary Tract Infection (UTI) Product Solution and Service
3.7 Date of Enter into Urinary Tract Infection (UTI) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Urinary Tract Infection (UTI) Breakdown Data by Type
4.1 Global Urinary Tract Infection (UTI) Historic Market Size by Type (2019-2024)
4.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2025-2030)
5 Urinary Tract Infection (UTI) Breakdown Data by Application
5.1 Global Urinary Tract Infection (UTI) Historic Market Size by Application (2019-2024)
5.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Urinary Tract Infection (UTI) Market Size (2019-2030)
6.2 North America Urinary Tract Infection (UTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Urinary Tract Infection (UTI) Market Size by Country (2019-2024)
6.4 North America Urinary Tract Infection (UTI) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urinary Tract Infection (UTI) Market Size (2019-2030)
7.2 Europe Urinary Tract Infection (UTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Urinary Tract Infection (UTI) Market Size by Country (2019-2024)
7.4 Europe Urinary Tract Infection (UTI) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size (2019-2030)
8.2 Asia-Pacific Urinary Tract Infection (UTI) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2019-2024)
8.4 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urinary Tract Infection (UTI) Market Size (2019-2030)
9.2 Latin America Urinary Tract Infection (UTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Urinary Tract Infection (UTI) Market Size by Country (2019-2024)
9.4 Latin America Urinary Tract Infection (UTI) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size (2019-2030)
10.2 Middle East & Africa Urinary Tract Infection (UTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2019-2024)
10.4 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Urinary Tract Infection (UTI) Introduction
11.1.4 Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.1.5 Novartis AG Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Urinary Tract Infection (UTI) Introduction
11.2.4 GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Dr. Reddy’s Laboratories Ltd.,
11.3.1 Dr. Reddy’s Laboratories Ltd., Company Detail
11.3.2 Dr. Reddy’s Laboratories Ltd., Business Overview
11.3.3 Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Introduction
11.3.4 Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.3.5 Dr. Reddy’s Laboratories Ltd., Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Urinary Tract Infection (UTI) Introduction
11.4.4 Pfizer Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Urinary Tract Infection (UTI) Introduction
11.5.4 Roche Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.5.5 Roche Recent Development
11.6 AstraZeneca,
11.6.1 AstraZeneca, Company Detail
11.6.2 AstraZeneca, Business Overview
11.6.3 AstraZeneca, Urinary Tract Infection (UTI) Introduction
11.6.4 AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.6.5 AstraZeneca, Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Urinary Tract Infection (UTI) Introduction
11.7.4 Cipla Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.7.5 Cipla Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Urinary Tract Infection (UTI) Introduction
11.8.4 Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.8.5 Johnson & Johnson Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Detail
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Urinary Tract Infection (UTI) Introduction
11.9.4 Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.9.5 Bayer AG Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Company Detail
11.10.2 Teva Pharmaceutical Industries Business Overview
11.10.3 Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Introduction
11.10.4 Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.10.5 Teva Pharmaceutical Industries Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Detail
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Urinary Tract Infection (UTI) Introduction
11.11.4 Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Urinary Tract Infection (UTI) Introduction
11.12.4 Sanofi Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.12.5 Sanofi Recent Development
11.13 Lily
11.13.1 Lily Company Detail
11.13.2 Lily Business Overview
11.13.3 Lily Urinary Tract Infection (UTI) Introduction
11.13.4 Lily Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.13.5 Lily Recent Development
11.14 Abbott
11.14.1 Abbott Company Detail
11.14.2 Abbott Business Overview
11.14.3 Abbott Urinary Tract Infection (UTI) Introduction
11.14.4 Abbott Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.14.5 Abbott Recent Development
11.15 JinShuiBao
11.15.1 JinShuiBao Company Detail
11.15.2 JinShuiBao Business Overview
11.15.3 JinShuiBao Urinary Tract Infection (UTI) Introduction
11.15.4 JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.15.5 JinShuiBao Recent Development
11.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
11.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Introduction
11.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.17 Sinopharm
11.17.1 Sinopharm Company Detail
11.17.2 Sinopharm Business Overview
11.17.3 Sinopharm Urinary Tract Infection (UTI) Introduction
11.17.4 Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.17.5 Sinopharm Recent Development
11.18 Borui Medicine
11.18.1 Borui Medicine Company Detail
11.18.2 Borui Medicine Business Overview
11.18.3 Borui Medicine Urinary Tract Infection (UTI) Introduction
11.18.4 Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.18.5 Borui Medicine Recent Development
11.19 Zhejiang Xianju Pharmaceutical
11.19.1 Zhejiang Xianju Pharmaceutical Company Detail
11.19.2 Zhejiang Xianju Pharmaceutical Business Overview
11.19.3 Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Introduction
11.19.4 Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.19.5 Zhejiang Xianju Pharmaceutical Recent Development
11.20 Sichuan Guorui Pharmaceutical
11.20.1 Sichuan Guorui Pharmaceutical Company Detail
11.20.2 Sichuan Guorui Pharmaceutical Business Overview
11.20.3 Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Introduction
11.20.4 Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.20.5 Sichuan Guorui Pharmaceutical Recent Development
11.21 Hengrui Pharmaceutical
11.21.1 Hengrui Pharmaceutical Company Detail
11.21.2 Hengrui Pharmaceutical Business Overview
11.21.3 Hengrui Pharmaceutical Urinary Tract Infection (UTI) Introduction
11.21.4 Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2019-2024)
11.21.5 Hengrui Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Upper Urinary Tract Infection
Table 3. Key Players of Lower Urinary Tract Infection
Table 4. Global Urinary Tract Infection (UTI) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Urinary Tract Infection (UTI) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Urinary Tract Infection (UTI) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Urinary Tract Infection (UTI) Market Share by Region (2019-2024)
Table 8. Global Urinary Tract Infection (UTI) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Urinary Tract Infection (UTI) Market Share by Region (2025-2030)
Table 10. Urinary Tract Infection (UTI) Market Trends
Table 11. Urinary Tract Infection (UTI) Market Drivers
Table 12. Urinary Tract Infection (UTI) Market Challenges
Table 13. Urinary Tract Infection (UTI) Market Restraints
Table 14. Global Urinary Tract Infection (UTI) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Urinary Tract Infection (UTI) Market Share by Players (2019-2024)
Table 16. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Tract Infection (UTI) as of 2023)
Table 17. Ranking of Global Top Urinary Tract Infection (UTI) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Urinary Tract Infection (UTI) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Urinary Tract Infection (UTI) Product Solution and Service
Table 21. Date of Enter into Urinary Tract Infection (UTI) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Urinary Tract Infection (UTI) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2019-2024)
Table 25. Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2025-2030)
Table 27. Global Urinary Tract Infection (UTI) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2019-2024)
Table 29. Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2025-2030)
Table 31. North America Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Urinary Tract Infection (UTI) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Urinary Tract Infection (UTI) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Urinary Tract Infection (UTI) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Urinary Tract Infection (UTI) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Urinary Tract Infection (UTI) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Urinary Tract Infection (UTI) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Urinary Tract Infection (UTI) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Novartis AG Company Detail
Table 47. Novartis AG Business Overview
Table 48. Novartis AG Urinary Tract Infection (UTI) Product
Table 49. Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 50. Novartis AG Recent Development
Table 51. GlaxoSmithKline Company Detail
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Urinary Tract Infection (UTI) Product
Table 54. GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 55. GlaxoSmithKline Recent Development
Table 56. Dr. Reddy’s Laboratories Ltd., Company Detail
Table 57. Dr. Reddy’s Laboratories Ltd., Business Overview
Table 58. Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Product
Table 59. Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 60. Dr. Reddy’s Laboratories Ltd., Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Urinary Tract Infection (UTI) Product
Table 64. Pfizer Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Urinary Tract Infection (UTI) Product
Table 69. Roche Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 70. Roche Recent Development
Table 71. AstraZeneca, Company Detail
Table 72. AstraZeneca, Business Overview
Table 73. AstraZeneca, Urinary Tract Infection (UTI) Product
Table 74. AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 75. AstraZeneca, Recent Development
Table 76. Cipla Company Detail
Table 77. Cipla Business Overview
Table 78. Cipla Urinary Tract Infection (UTI) Product
Table 79. Cipla Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 80. Cipla Recent Development
Table 81. Johnson & Johnson Company Detail
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Urinary Tract Infection (UTI) Product
Table 84. Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Bayer AG Company Detail
Table 87. Bayer AG Business Overview
Table 88. Bayer AG Urinary Tract Infection (UTI) Product
Table 89. Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 90. Bayer AG Recent Development
Table 91. Teva Pharmaceutical Industries Company Detail
Table 92. Teva Pharmaceutical Industries Business Overview
Table 93. Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Product
Table 94. Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 95. Teva Pharmaceutical Industries Recent Development
Table 96. Boehringer Ingelheim Company Detail
Table 97. Boehringer Ingelheim Business Overview
Table 98. Boehringer Ingelheim Urinary Tract Infection (UTI) Product
Table 99. Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 100. Boehringer Ingelheim Recent Development
Table 101. Sanofi Company Detail
Table 102. Sanofi Business Overview
Table 103. Sanofi Urinary Tract Infection (UTI) Product
Table 104. Sanofi Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Lily Company Detail
Table 107. Lily Business Overview
Table 108. Lily Urinary Tract Infection (UTI) Product
Table 109. Lily Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 110. Lily Recent Development
Table 111. Abbott Company Detail
Table 112. Abbott Business Overview
Table 113. Abbott Urinary Tract Infection (UTI) Product
Table 114. Abbott Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 115. Abbott Recent Development
Table 116. JinShuiBao Company Detail
Table 117. JinShuiBao Business Overview
Table 118. JinShuiBao Urinary Tract Infection (UTI) Product
Table 119. JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 120. JinShuiBao Recent Development
Table 121. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
Table 122. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 123. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Product
Table 124. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 125. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 126. Sinopharm Company Detail
Table 127. Sinopharm Business Overview
Table 128. Sinopharm Urinary Tract Infection (UTI) Product
Table 129. Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 130. Sinopharm Recent Development
Table 131. Borui Medicine Company Detail
Table 132. Borui Medicine Business Overview
Table 133. Borui Medicine Urinary Tract Infection (UTI) Product
Table 134. Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 135. Borui Medicine Recent Development
Table 136. Zhejiang Xianju Pharmaceutical Company Detail
Table 137. Zhejiang Xianju Pharmaceutical Business Overview
Table 138. Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Product
Table 139. Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 140. Zhejiang Xianju Pharmaceutical Recent Development
Table 141. Sichuan Guorui Pharmaceutical Company Detail
Table 142. Sichuan Guorui Pharmaceutical Business Overview
Table 143. Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Product
Table 144. Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 145. Sichuan Guorui Pharmaceutical Recent Development
Table 146. Hengrui Pharmaceutical Company Detail
Table 147. Hengrui Pharmaceutical Business Overview
Table 148. Hengrui Pharmaceutical Urinary Tract Infection (UTI) Product
Table 149. Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2019-2024) & (US$ Million)
Table 150. Hengrui Pharmaceutical Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urinary Tract Infection (UTI) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Urinary Tract Infection (UTI) Market Share by Type: 2023 VS 2030
Figure 3. Upper Urinary Tract Infection Features
Figure 4. Lower Urinary Tract Infection Features
Figure 5. Global Urinary Tract Infection (UTI) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Urinary Tract Infection (UTI) Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Self-administered Case Studies
Figure 10. Others Case Studies
Figure 11. Urinary Tract Infection (UTI) Report Years Considered
Figure 12. Global Urinary Tract Infection (UTI) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Urinary Tract Infection (UTI) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Urinary Tract Infection (UTI) Market Share by Region: 2023 VS 2030
Figure 15. Global Urinary Tract Infection (UTI) Market Share by Players in 2023
Figure 16. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Tract Infection (UTI) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Urinary Tract Infection (UTI) Revenue in 2023
Figure 18. North America Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Urinary Tract Infection (UTI) Market Share by Country (2019-2030)
Figure 20. United States Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Urinary Tract Infection (UTI) Market Share by Country (2019-2030)
Figure 24. Germany Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Region (2019-2030)
Figure 32. China Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Urinary Tract Infection (UTI) Market Share by Country (2019-2030)
Figure 40. Mexico Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Country (2019-2030)
Figure 44. Turkey Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Urinary Tract Infection (UTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Novartis AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 48. Dr. Reddy’s Laboratories Ltd., Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 51. AstraZeneca, Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 52. Cipla Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 53. Johnson & Johnson Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 54. Bayer AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 57. Sanofi Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 58. Lily Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 59. Abbott Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 60. JinShuiBao Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 61. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 62. Sinopharm Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 63. Borui Medicine Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 64. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 65. Sichuan Guorui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 66. Hengrui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
